Jay J Lee, MD
Internal Medicine · San Diego
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 21 years
- Perelman School of Med at the University of Pennsylvania, 2005
Offices
3 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Looking this up.
Hospitals listed: Kaiser Foundation Hospital - Zion. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A97063 · Current
Licensed to practise in California · since 2006 · expires 2028-03-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - San DiegoSan Diego, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.204, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.627, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - San Diego
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.204 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.627 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.5 (0.45 to 2.54) · 400 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 332 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 5,878 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,732 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,721 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.73 (1.33 to 6.12) · 434 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.35 (0.72 to 3.98) · 421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (0.49 to 18.28) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.41 (1.35 to 9.47) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.61 (0 to 1.51) · 1,270 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 279 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.757 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.629 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 158 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,165 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 33.1 · 30 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 960 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 285 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,483 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$3,582
Medicare paid this office $3,582 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 69 · Health risk score 2.87. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 65%.
The office billed $13,021, Medicare allowed $4,560 and paid $3,582; for 57 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 57 | 69 | 2.87 | $13,021 | $3,582 |
| 2022 | 12 | 25 | 71 | 2.25 | $5,609 | $1,756 |
| 2021 | 13 | 43 | 66 | 2.69 | $9,971 | $2,831 |
| 2020 | 13 | 23 | 65 | 2.86 | $9,207 | $2,164 |
| 2019 | 20 | 46 | 73 | 1.45 | $13,286 | $3,133 |
| 2018 | 136 | 291 | 77 | 2.18 | $87,262 | $26,404 |
| 2017 | 248 | 580 | 79 | 1.98 | $171,095 | $53,272 |
| 2016 | 186 | 541 | 80 | 2.56 | $158,567 | $49,539 |
| 2015 | 217 | 530 | 79 | 2.38 | $164,200 | $54,096 |
| 2014 | 206 | 502 | 79 | 2.55 | $162,593 | $48,681 |
| 2013 | 196 | 435 | 78 | 2.04 | $147,465 | $42,303 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,812 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,030 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $4,264 | $64 |
| Hospital discharge day management, more than 30 minutes | 33 | $3,228 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,299 | $115 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,006 | $35 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $17,865 | $93 |
| Hospital discharge day management, more than 30 minutes | 86 | $8,523 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 75 | $8,338 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,799 | $177 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,739 | $122 |
| Hospital observation care on day of discharge | 18 | $1,179 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,109 | $35 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $24,992 | $91 |
| Hospital discharge day management, more than 30 minutes | 78 | $7,917 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,709 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,910 | $175 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,935 | $121 |
| Hospital observation care on day of discharge | 21 | $1,426 | $65 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $26,250 | $96 |
| Hospital discharge day management, more than 30 minutes | 77 | $8,157 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $8,121 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,906 | $67 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,883 | $171 |
| Hospital observation care on day of discharge | 20 | $1,361 | $68 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $24,780 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,904 | $176 |
| Hospital discharge day management, more than 30 minutes | 80 | $7,890 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $2,829 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,448 | $121 |
| Hospital observation care on day of discharge | 16 | $1,025 | $64 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $17,971 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,987 | $169 |
| Hospital discharge day management, more than 30 minutes | 59 | $5,694 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,335 | $61 |
| Hospital observation care on day of discharge | 22 | $1,384 | $63 |
Drugs they prescribed that Part D paid
$42,617
Pharmacies billed $42,617 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (18 of 480) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
409 generic and fewer than 11 brand-name prescriptions · $42,617 in drug cost · 88 antibiotic prescriptions to 65 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 20 | $18,530 | $927 |
| Humulin N | 12 | $2,167 | $181 |
| Cefpodoxime Proxetil | 29 | $623 | $21 |
| Furosemide | 23 | $277 | $12 |
| Metoprolol | 25 | $244 | $10 |
See all 12 drugs
| Eliquis | 20 | $18,530 | $927 |
| Humulin N | 12 | $2,167 | $181 |
| Cefpodoxime Proxetil | 29 | $623 | $21 |
| Furosemide | 23 | $277 | $12 |
| Metoprolol | 25 | $244 | $10 |
| Atorvastatin | 19 | $210 | $11 |
| Omeprazole | 17 | $200 | $12 |
| Doxycycline Monohydrate | 18 | $168 | $9 |
| Amlodipine Besylate | 11 | $131 | $12 |
| Pantoprazole | 11 | $130 | $12 |
| Lisinopril | 11 | $111 | $10 |
| Prednisone | 15 | $103 | $7 |
Year by year
| 2024 | 480 | 195 | 4% (18) | None | $42,617 |
| 2023 | 447 | 193 | 5% (22) | None | $45,473 |
| 2022 | 372 | 171 | 4% (15) | None | $19,657 |
| 2021 | 399 | 178 | 5% (21) | None | $31,976 |
| 2020 | 340 | 146 | 6% (19) | None | $88,743 |
| 2019 | 363 | 171 | 9% (32) | None | $23,695 |
| 2018 | 90 | 50 | None | 23% | $5,713 |
| 2017 | 109 | 46 | None | 10% | $6,836 |
| 2016 | 99 | 50 | None | 13% | $5,083 |
| 2015 | 79 | 44 | None | None | $1,789 |
| 2014 | 93 | 41 | None | 23% | $5,871 |
| 2013 | 92 | 40 | None | 18% | $3,478 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Cefpodoxime Proxetil | 21 | $503 | $24 |
| Furosemide | 27 | $366 | $14 |
| Diltiazem 24hr Er (Cd) | 11 | $253 | $23 |
| Metoprolol | 25 | $235 | $9 |
| Clopidogrel | 14 | $204 | $15 |
| Doxycycline Monohydrate | 19 | $190 | $10 |
| Amoxicillin-Clavulanate Potass | 12 | $177 | $15 |
| Prednisone | 17 | $163 | $10 |
| Pantoprazole | 12 | $158 | $13 |
2022: 10 drugs
| Potassium Chloride | 13 | $523 | $40 |
| Cefpodoxime Proxetil | 23 | $490 | $21 |
| Clopidogrel | 12 | $230 | $19 |
| Furosemide | 17 | $230 | $14 |
| Pantoprazole | 17 | $216 | $13 |
| Metoprolol | 21 | $173 | $8 |
| Atorvastatin | 12 | $136 | $11 |
| Omeprazole | 12 | $110 | $9 |
| Doxycycline Monohydrate | 12 | $101 | $8 |
| Cephalexin | 11 | $88 | $8 |
2021: 10 drugs
| Eliquis | 16 | $12,406 | $775 |
| Pradaxa | 12 | $3,556 | $296 |
| Cefpodoxime Proxetil | 11 | $316 | $29 |
| Furosemide | 22 | $221 | $10 |
| Prednisone | 16 | $204 | $13 |
| Metoprolol | 25 | $198 | $8 |
| Omeprazole | 16 | $175 | $11 |
| Cephalexin | 14 | $140 | $10 |
| Sulfamethoxazole-Trimethoprim | 11 | $101 | $9 |
| Hydrocodone-Acetaminophen | 12 | $98 | $8 |
2020: 4 drugs
| Amlodipine Besylate | 17 | $189 | $11 |
| Prednisone | 18 | $171 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $155 | $14 |
| Lisinopril | 11 | $114 | $10 |
2019: 7 drugs
| Cefpodoxime Proxetil | 16 | $346 | $22 |
| Furosemide | 19 | $221 | $12 |
| Atorvastatin | 11 | $219 | $20 |
| Prednisone | 19 | $186 | $10 |
| Hydrocodone-Acetaminophen | 18 | $129 | $7 |
| Doxycycline Monohydrate | 11 | $111 | $10 |
| Metoprolol | 12 | $91 | $8 |
2017: 3 drugs
| Atorvastatin | 12 | $95 | $8 |
| Metoprolol | 14 | $75 | $5 |
| Clopidogrel | 14 | $70 | $5 |
2014: 1 drug
| Ampicillin | 11 | $1,350 | $123 |
Money from drug and device companies
$124 in 2024
| 2024 | 1 | 1 | None | $124 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 2 | 3 | None | $56 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | None | $124 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Meals · 2024-09-08 | None | $124 |
See earlier years (2021, 2020)
2021: $17
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
2020: $56
| Sanofi-Aventis U.S. | Multaq | $42 | 2 payments
|
| Akcea Therapeutics | Tegsedi | $15 | 1 payment
|
Professional record
- NPI
- 1992985873
- Licence
- CA A97063California A97063: Current · expires 2028-03-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2005 · 21 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-11-08
- NPI last updated
- 2021-12-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.